Current HIV/AIDS Reports

Papers
(The TQCC of Current HIV/AIDS Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Adventures in COVID-19 Policy Modeling: Education Edition69
Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory54
Challenges and Opportunities in Big Data Science to Address Health Inequities and Focus the HIV Response50
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries43
Syndemic Theory and Its Use in Developing Health Interventions and Programming: A Scoping Review43
Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?34
Examining the Use of HIV Self-Testing to Support PrEP Delivery: a Systematic Literature Review32
Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic30
Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review29
Ethical Perspectives in Using Technology-Enabled Research for Key HIV Populations in Rights-Constrained Settings27
Interventions to Improve Adolescent HIV Care Outcomes26
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?25
Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States25
Consolidated Overview of Notifiable Adverse Events in the U.S. President’s Emergency Plan for AIDS Relief’s Voluntary Medical Male Circumcision Program Through 202024
More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure24
Risk Compensation in Voluntary Medical Male Circumcision Programs24
Risk-Based Screening Tools to Optimise HIV Testing Services: a Systematic Review23
Intestinal Microbiota and Aging in People with HIV—What We Know and What We Don’t23
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa22
Current Status of HIV-Stigma Reduction Interventions: A Need to Address the Root Causes at Multiple Levels22
PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice20
Update on Central Nervous System Effects of HIV in Adolescents and Young Adults20
Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy19
A Review of Serious Gaming as an Intervention for HIV Prevention17
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview17
Future of bNAbs in HIV Treatment17
Transition to Adult Care for Young People Living with HIV17
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program17
VMMC Programmatic Successes and Challenges: Western Kenya Case Study16
Sex Differences in Metabolic Disorders of Aging and Obesity in People with HIV16
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa15
Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence15
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy15
Intervention Approaches to Address Intimate Partner Violence and HIV: a Scoping Review of Recent Research14
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions14
Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead14
HIV Prevention Tools Across the Pregnancy Continuum: What Works, What Does Not, and What Can We Do Differently?14
Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review14
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era14
Update on Vaccination Recommendations for Adults with HIV14
Fatty Liver Disease: Enter the Metabolic Era13
Mpox and HIV: a Narrative Review13
HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups13
PEPFAR’s Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa13
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations12
The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies12
0.055926084518433